- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Atezolizumab (adjuvant)
Total 9045 results
-
Queen Mary University of LondonHoffmann-La RocheUnknownBladder CancerUnited Kingdom, France, Spain, Netherlands
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
GlaxoSmithKlineBiological E. LimitedRecruiting
-
Nykode Therapeutics ASARoche Pharma AG; GOG FoundationRecruitingCervical Cancer | HPV-Related Malignancy | HPV-Related Cervical CarcinomaUnited States
-
The University of Texas Medical Branch, GalvestonNational Cancer Institute (NCI)TerminatedGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Intestine Cancer | Gallbladder Cancer | Extrahepatic Bile Duct CancerUnited States
-
Hoffmann-La RocheCompleted
-
Tracon Pharmaceuticals Inc.Active, not recruitingSolid Tumor | Metastatic CancerUnited States
-
Hoffmann-La RocheTerminatedTriple Negative Breast Cancer | Advanced Ovarian CancerUnited Kingdom, United States, Australia, Denmark, Canada
-
Genentech, Inc.CompletedHematologic Malignancies | TumorsSpain, France, United States, United Kingdom
-
McGill University Health Centre/Research Institute...Unknown
-
Basilea PharmaceuticaCompletedUrothelial CarcinomaUnited Kingdom, Korea, Republic of, Italy, Canada, France, Spain, Germany, United States, Hungary, Australia, Poland, Switzerland, Czechia, Austria
-
Base Therapeutics (Shanghai) Co., Ltd.Shanghai 10th People's HospitalEnrolling by invitation
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
Beijing Syngentech Co., Ltd.Not yet recruitingHepatocellular Carcinoma
-
Bavarian NordicCompletedBladder CancerUnited States
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Denmark, Spain, Canada, France, Italy, Netherlands
-
University of Michigan Rogel Cancer CenterTerminated
-
Niharika MettuRoche-GenentechWithdrawnMetastatic Colorectal CancerUnited States
-
Institute of Cancer Research, United KingdomHoffmann-La RocheRecruitingSolid Tumor | Glioblastoma Multiforme | Prostate Cancer MetastaticUnited Kingdom
-
CHA UniversityRecruitingHepatocellular CarcinomaKorea, Republic of
-
Base Therapeutics (Shanghai) Co., Ltd.The General Hospital of Eastern Theater CommandRecruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Innovive PharmaceuticalsCompletedMyelodysplastic Syndromes | Leukemia | Lung Cancer | Malignant Mesothelioma | Primary Peritoneal Cavity CancerUnited States
-
University of VirginiaNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
GlaxoSmithKlineUnknownMelanoma (Skin)United States
-
National Institute of Allergy and Infectious Diseases...Emory UniversityCompletedInfluenza A Virus, H5N1 SubtypeUnited States
-
I-Mab Biopharma US LimitedNo longer availableCancerUnited States
-
The Netherlands Cancer InstituteRoche Pharma AGTerminatedBreast CancerNetherlands
-
The Lymphoma Academic Research OrganisationRoche Pharma AGTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin LymphomaFrance
-
Hoffmann-La RocheWithdrawn
-
Darell BignerGenentech, Inc.; Istari Oncology, Inc.Withdrawn
-
U.S. Army Medical Research and Development CommandGlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)Completed
-
Affimed GmbHRecruitingAdvanced Solid TumorUnited States, Spain, United Kingdom, Korea, Republic of, Poland
-
Hoffmann-La RocheCompletedLymphomaPoland, United States, Germany
-
Fox Chase Cancer CenterStand Up To Cancer; Van Andel Research InstituteActive, not recruitingUrothelial CarcinomaUnited States
-
Oslo University HospitalTerminatedNon-small Cell Lung CancerNorway
-
BiondVax Pharmaceuticals ltd.Completed
-
Glenmark Specialty S.A.RecruitingLymphoma | Advanced Solid TumorUnited States, India
-
Samsung Medical CenterNot yet recruitingPremenopausal HR+/HER2- Metastatic Breast CancerKorea, Republic of
-
James BrugarolasRecruitingRenal Cell CarcinomaUnited States
-
ExelixisActive, not recruitingRenal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Castration-resistant Prostate Cancer | Urothelial Carcinoma | Differentiated Thyroid Cancer | Gastroesophageal... and other conditionsUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
CHA UniversityHoffmann-La RocheCompletedAdvanced Hepatocellular CarcinomaKorea, Republic of
-
Centre Antoine LacassagneRoche Pharma AG; Centre Hospitalier Universitaire de CaenRecruitingSarcoma | RadiosurgeryFrance
-
Regeneron PharmaceuticalsNovella ClinicalCompletedNon Small Cell Lung CancerUnited States
-
University of UtahGenentech, Inc.; Bavarian NordicWithdrawnProstate AdenocarcinomaUnited States
-
Immune Response BioPharma, Inc.Not yet recruitingMultiple SclerosisUnited States
-
National Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
National Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Sun Yat-sen UniversityRecruitingHepatocellular CarcinomaChina
-
Nancy Lin, MDGenentech, Inc.Active, not recruitingHER2-positive Metastatic Breast Cancer | Central Nervous System MetastasesUnited States